MAX Chat
Company Analysis Hims & Hers Health, Inc.
1. Summary
Advantages
- The stock's return over the last year (256.07%) is higher than the sector average (39.17%).
- Current debt level 1.6% is below 100% and has decreased over 5 years from 2.08%.
- The company's current efficiency (ROE=30.71%) is higher than the sector average (ROE=5.84%)
Disadvantages
- Price (57.15 $) is higher than fair price (7.68 $)
- Dividends (0%) are below the sector average (1.51%).
Similar companies
2. Share price and performance
2.1. Share price
2.3. Market efficiency
| Hims & Hers Health, Inc. | High Tech | Index | |
|---|---|---|---|
| 7 days | 1.5% | 10.9% | 0.6% |
| 90 days | 93.8% | 22% | 19.2% |
| 1 year | 256.1% | 39.2% | 14.2% |
HIMS vs Sector: Hims & Hers Health, Inc. has outperformed the "High Tech" sector by 216.9% over the past year.
HIMS vs Market: Hims & Hers Health, Inc. has outperformed the market by 241.91% over the past year.
Slightly volatile price: HIMS is more volatile than the rest of the market on "New York Stock Exchange" over the last 3 months, with typical deviations of about +/- 5-15% per week.
Long period: HIMS with weekly volatility of 4.92% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Above fair price: The current price (57.15 $) is higher than the fair price (7.68 $).
Price is higher than fair: The current price (57.15 $) is 86.6% higher than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (45.43) is lower than that of the sector as a whole (45.73).
P/E vs Market: The company's P/E (45.43) is lower than that of the market as a whole (61.8).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (12.01) is higher than that of the sector as a whole (5.78).
P/BV vs Market: The company's P/BV (12.01) is lower than that of the market as a whole (20.58).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (3.88) is higher than that of the sector as a whole (3.42).
P/S vs Market: The company's P/S indicator (3.88) is lower than that of the market as a whole (15.97).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (69.84) is higher than that of the sector as a whole (14.39).
EV/Ebitda vs Market: The company's EV/Ebitda (69.84) is higher than that of the market as a whole (18.72).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Negative and has fallen by -159.27% over the last 5 years.
Accelerating profitability: The return for the last year (0%) exceeds the average return for 5 years (-159.27%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-785.98%).
5.4. ROE
ROE vs Sector: The company's ROE (30.71%) is higher than that of the sector as a whole (5.84%).
ROE vs Market: The company's ROE (30.71%) is lower than that of the market as a whole (42.63%).
5.5. ROA
ROA vs Sector: The company's ROA (21.94%) is higher than that of the sector as a whole (0.2911%).
ROA vs Market: The company's ROA (21.94%) is lower than that of the market as a whole (23.26%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (-23%) is lower than that of the sector as a whole (-10.19%).
ROIC vs Market: The company's ROIC (-23%) is lower than that of the market as a whole (9.17%).
7. Dividends
7.1. Dividend yield vs Market
Low yield: The dividend yield of the company 0% is below the average for the sector '1.51%.
7.2. Stability and increase in payments
Unstable dividends: The company's dividend yield 0% has not been consistently paid over the past 7 years, DSI=0.
Weak dividend growth: The company's dividend yield 0% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (0%) are at an uncomfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
